Carlsmed, Inc. (CARL)Healthcare | Health Information Services | Carlsbad, United States | NasdaqGS
13.95 USD
+0.10
(0.722%)
⇧
(Oct. 15, 2026, 4 p.m.
EDT)
After hours: 13.95 |
Hot Take ↕ | Oct. 10, 2026, 4:56 a.m. EDT
The stock presents a classic case of aggressive analyst optimism clashing with deteriorating operational reality. While five analysts project significant upside and recent headlines celebrate revenue beating estimates, the underlying financials tell a starkly different story: the company is burning cash, posting negative operating margins, and generating negative free cash flow. The balance sheet is surprisingly liquid due to massive cash reserves relative to debt, which prevents an immediate 'avoid' rating, but the inability to convert revenue into profit suggests the business model is currently broken or in a prolonged turnaround phase. Technically, the price is hovering near its 52-week lows, offering some relief from a sharp drop, yet the lack of a multi-year price history and the absence of any dividend support make this a speculative hold rather than a conviction trade. The statistical models offer no directional guidance, reinforcing the view that the current price action is driven by sentiment rather than sustainable value creation. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.110198 |
| AutoETS | 0.110603 |
| MSTL | 0.111850 |
| AutoTheta | 0.123636 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 0.90 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.335 |
| Excess Kurtosis | -1.08 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 26.015 |
| Revenue per Share | 2.482 |
| Market Cap | 380,873,280 |
| Forward P/E | -10.11 |
| Profit Margins | -57.42% |
| Website | https://carlsmed.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.016140819 |
| Address1 | 1,800 Aston Avenue |
| Address2 | Suite 100 |
| All Time High | 17.23 |
| All Time Low | 8.5 |
| Ask | 17.92 |
| Ask Size | 2 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.4 - Strong Buy |
| Average Daily Volume10 Day | 87,400 |
| Average Daily Volume3 Month | 113,940 |
| Average Volume | 113,940 |
| Average Volume10Days | 87,400 |
| Bid | 10.14 |
| Bid Size | 2 |
| Board Risk | 9 |
| Book Value | 3.094 |
| City | Carlsbad |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 13.95 |
| Current Ratio | 8.841 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 14.32 |
| Day Low | 13.85 |
| Debt To Equity | 26.015 |
| Display Name | Carlsmed |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,785,961,800 |
| Earnings Call Timestamp Start | 1,785,961,800 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -38,256,000 |
| Ebitda Margins | -0.60441 |
| Enterprise To Ebitda | -8.197 |
| Enterprise To Revenue | 4.954 |
| Enterprise Value | 313,566,272 |
| Eps Current Year | -1.41 |
| Eps Forward | -1.38 |
| Eps Trailing Twelve Months | -1.08 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.9524 |
| Fifty Day Average Change | -1.0024004 |
| Fifty Day Average Change Percent | -0.06703943 |
| Fifty Two Week Change Percent | 1.6140819 |
| Fifty Two Week High | 17.23 |
| Fifty Two Week High Change | -3.2799997 |
| Fifty Two Week High Change Percent | -0.19036563 |
| Fifty Two Week Low | 8.5 |
| Fifty Two Week Low Change | 5.45 |
| Fifty Two Week Low Change Percent | 0.64117646 |
| Fifty Two Week Range | 8.5 - 17.23 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,753,277,400,000 |
| Float Shares | 15,646,656 |
| Forward Eps | -1.38 |
| Forward P E | -10.108696 |
| Free Cashflow | -26,408,376 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 127 |
| Fullday Change | 0.09999943 |
| Fullday Change Percent | 0.7220175 |
| Fullday Price | 13.95 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.76628 |
| Gross Profits | 48,502,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.45036998 |
| Held Percent Institutions | 0.40432 |
| Implied Shares Outstanding | 27,302,743 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Ipo Expected Date | 2,025-07-23 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California. |
| Long Name | Carlsmed, Inc. |
| Market | us_market |
| Market Cap | 380,873,280 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_629940925 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -36,345,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 403,534,541 |
| Number Of Analyst Opinions | 5 |
| Open | 13.91 |
| Operating Cashflow | -34,145,000 |
| Operating Margins | -0.58268 |
| Overall Risk | 8 |
| Phone | 760 766 1923 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 13.95 |
| Post Market Time | 1,792,094,411 |
| Previous Close | 13.85 |
| Price Eps Current Year | -9.893617 |
| Price Hint | 2 |
| Price To Book | 4.5087266 |
| Price To Sales Trailing12 Months | 6.017431 |
| Profit Margins | -0.57422 |
| Quick Ratio | 8.308 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.4 |
| Region | US |
| Regular Market Change | 0.0999994 |
| Regular Market Change Percent | 0.722018 |
| Regular Market Day High | 14.32 |
| Regular Market Day Low | 13.85 |
| Regular Market Day Range | 13.85 - 14.32 |
| Regular Market Open | 13.91 |
| Regular Market Previous Close | 13.85 |
| Regular Market Price | 13.95 |
| Regular Market Time | 1,792,094,401 |
| Regular Market Volume | 33,273 |
| Return On Assets | -0.28186 |
| Return On Equity | -0.66141 |
| Revenue Growth | 0.567 |
| Revenue Per Share | 2.482 |
| Sand P52 Week Change | 0.16440773 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 27,302,743 |
| Shares Percent Shares Out | 0.038599998 |
| Shares Short | 1,053,927 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 1,100,310 |
| Short Name | Carlsmed, Inc. |
| Short Percent Of Float | 0.1031 |
| Short Ratio | 13.12 |
| Source Interval | 15 |
| State | CA |
| Symbol | CARL |
| Target High Price | 24.0 |
| Target Low Price | 17.0 |
| Target Mean Price | 19.4 |
| Target Median Price | 18.0 |
| Total Cash | 89,224,000 |
| Total Cash Per Share | 3.268 |
| Total Debt | 21,917,000 |
| Total Revenue | 63,295,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.08 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 12.303275 |
| Two Hundred Day Average Change | 1.6467247 |
| Two Hundred Day Average Change Percent | 0.13384442 |
| Type Disp | Equity |
| Volume | 33,273 |
| Website | https://carlsmed.com |
| Zip | 92,008 |